ApconiX

Alderley Edge,  Cheshire 
United Kingdom
http://www.apconix.com

Welcome to the ApconiX booth at ACT 2022.

ApconiX are experts in cardiac and CNS electrophysiology, target safety assessments and in all aspects of nonclinical toxicology and DMPK project support. ApconiX was formed with the objective to give companies of all sizes access to the breadth and depth of safety expertise generally only available in large pharma. Our lab team conduct hERG and CiPA cardiac screening assays and have developed in vitro assays to better understand CNS liability (iLA seizure® and iLA CNS®) based on ion channel screening and microelectrode array analysis of human stem cells. We continue to carry out research in other fields relevant to efficacy and safety in the CNS. The ApconiX Safety Science Team combines toxicology expertise and advanced data science, offering customized Acuity® target safety assessments (TSAs). The team also conducts modality or asset focused reports and will support you in understanding and optimizing project safety profiles. Our consultancy team provide a flexible nonclinical drug safety and DMPK support to your discovery and development team, from as little as one or two hours to long term.